Methylglyoxal induces mitochondrial dysfunction and cell death in liver

Toxicological Research

Volumn 30, Issue 3, 2014, Pages 193-198

  Seo, Kyuhwa ^a   Ki, Sung Hwan ^a   Shin, Sang Mi ^a  

^a Chosun University   (South Korea)

Author keywords

Liver; Methylglyoxal; Mitochondrial dysfunction; Oxidative stress; Reactive oxygen species

Indexed keywords

MUS;

EID: 84907824946     PISSN: 19768257     EISSN: 22342753     Source Type: Journal    
DOI: 10.5487/TR.2014.30.3.193     Document Type: Article

References (32)

1. Gaens, K.H., Stehouwer, C.D. and Schalkwijk, C.G. (2013) Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr. Opin. Lipidol., 24, 4-11.
2. Shinohara, M., Thornalley, P.J., Giardino, I., Beisswenger, P., Thorpe, S.R., Onorato, J. and Brownlee, M. (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest., 101, 1142-1147.
3. Rabbani, N. and Thornalley, P.J. (2011) Glyoxalase in diabetes, obesity and related disorders. Semin. Cell Dev. Biol., 22, 309-317.
4. Tappy, L. and Lê, K.A. (2012) Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res. Hepatol. Gastroenterol., 36, 554-560.
5. Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G.E. and Vlassara, H. (2012) Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc. Natl. Acad. Sci. U.S.A., 109, 15888-15893.
6. Beisswenger, P.J., Howell, S.K., Touchette, A.D., Lal, S. and Szwergold, B.S. (1999) Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes, 48, 198-202.
7. Mukohda, M., Okada, M., Hara, Y. and Yamawaki, H. (2012) Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility. J. Pharmacol. Sci., 118, 303-310.
8. Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N.Y. Acad. Sci., 1243, 88-102.
9. Brouwers, O., Niessen, P.M., Ferreira, I., Miyata, T., Scheffer, P.G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C.D. and Schalkwijk, C.G. (2011) Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J. Biol. Chem., 286, 1374-1380.
10. Ruggiero-Lopez, D., Lecomte, M., Moinet, G., Patereau, G., Lagarde, M. and Wiernsperger, N. (1999) Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation. Biochem. Pharmacol., 58, 1765-1773.
11. Lee, B.H., Hsu, W.H., Chang, Y.Y., Kuo, H.F., Hsu, Y.W. and Pan, T.M. (2012) Ankaflavin: a natural novel PPARn agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radical Biol. Med., 53, 2008-2016.
12. Jiang, G. and Zhang, B.B. (2003) Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab., 284, E671-678.
13. Marceau, P., Biron, S., Hould, F.S., Marceau, S., Simard, S., Thung, S.N. and Kral, J.G. (1999) Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab., 84, 1513-1517.
14. Pun, P.B., Logan, A., Darley-Usmar, V., Chacko, B., Johnson, M.S., Huang, G.W., Rogatti, S., Prime, T.A., Methner, C., Krieg, T., Fearnley, I.M., Larsen, L., Larsen, D.S., Menger, K.E., Collins, Y., James, A.M., Kumar, G.D., Hartley, R.C., Smith, R.A. and Murphy, M.P. (2014) A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes. Free Radical Biol. Med., 67, 437-450.
15. Ren, J., Pulakat, L., Whaley-Connell, A. and Sowers, J.R. (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med., 88, 993-1001.
16. Kim, J.S., He, L. and Lemasters, J.J. (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun., 304, 463-470.
17. Lemasters, J.J., Nieminen, A.L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A. and Herman, B. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta, 1366, 177-196.
18. Shin, S.M., Cho, I.J. and Kim, S.G. (2009) Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol., 76, 884-895.
19. Yu, S.W., Wang, H., Poitras, M.F., Coombs, C., Bowers, W.J., Federoff, H.J., Poirier, G.G., Dawson, T.M. and Dawson, V.L. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297, 259-263.
20. Yu, S.W., Andrabi, S.A., Wang, H., Kim, N.S., Poirier, G.G., Dawson, T.M. and Dawson, V.L. (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U.S.A., 103, 18314-18319.
21. Rolo, A.P. and Palmeira, C.M. (2006) Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol., 212, 167-178.
22. Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D. and Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem., 269, 9889-9897.
23. Meister, A. and Anderson. M.E. (1983) Glutathione. Annu. Rev. Biochem., 52, 711-760.
24. Choudhary, D., Chandra, D. and Kale, R.K. (1997) Influence of methylglyoxal on antioxidant enzymes and oxidative damage. Toxicol. Lett., 93, 141-152.
25. Rej, R. (1978) Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin. Chem., 24, 1971-1979.
26. Cheng, A.S., Cheng, Y.H., Chiou, C.H. and Chang, T.L. (2012) Resveratrol upregulates Nrf2 Expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J. Agric. Food Chem., 60, 9180-9187.
27. Masterjohn, C., Mah, E., Park, Y., Pei, R., Lee, J., Manautou, J.E. and Bruno, R.S. (2013) Acute glutathione depletion induces hepatic methylglyoxal accumulation by impairing its detoxification to D-lactate. Exp. Biol. Med. (Maywood), 238, 360-369.
28. Li, W., Xu, H., Hu, Y., He, P., Ni, Z., Xu, H., Zhang, Z. and Dai, H. (2013) Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress. PLoS One, 8, e76025.
29. Fiory, F., Lombardi, A., Miele, C., Giudicelli, J., Beguinot, F. and Van Obberghen, E. (2011) Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia, 54, 2941-2952.
30. Li, W., Maloney, R.E., Circu, M.L., Alexander, J.S. and Aw, T.Y. (2013) Acute carbonyl stress induces occludin glycation and brain microvascular endothelial barrier dysfunction: role for glutathione-dependent metabolism of methylglyoxal. Free Radical Biol. Med., 54, 51-61.
31. Sorci, G., Riuzzi, F., Giambanco, I. and Donato, R. (2013) RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys. Acta, 1833, 101-109.
32. Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2012) The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vasc. Pharmacol., 57, 160-167.